Revolutionizing diabetes treatment. Betalin is currently carrying pre-clinical studies and in discussions with both the Human Tissue Association (UK) and Food Drug Association (US) to begin clinical trials.
Betalin Therapeutics licensed the novel Engineered Micro Pancreas (EMP) technology developed at The Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development.
The EMP aims to restore normal blood glucose levels by mimicking the function of
the pancreas using islet cells encapsulated within a micro-organ matrix scaffold. Betalin has produced some promising results and we hope to submit a package soon to the HTA to begin our first in-man studies.
When you eat, your food is broken down into glucose (sugar), this in turn increases you blood glucose levels. Insulin is a hormone and is released from the beta cells in the islet cells of your pancreas. Insulin helps facilitate the glucose into our cells from the blood, decreasing blood glucoses levels and either provides cells with energy or stores it for later use.
Diabetes is a disease in which the body cannot regulated blood glucose levels efficiently due to insulin abnormalities. Diabetes is spilt into an umbrella of types, the most prevalent being type I diabetes (where your body doesn’t produce insulin) and type II diabetes (when you don’t produce a sufficient amount of insulin).
Healthy Individual
Type I Diabetic
Type II Diabetic
Having diabetes requires constant daily monitoring to keep blood glucose in range
Uncontrolled diabetes can lead to serious health complication such as blindness, amputation and cardiovascular problems
The Global cost of diabetes and its related illnesses is set to double by 2030 to $2.5 trillion
Funded by:
Partially funded by:
Partially funded by:
Using the state of the art technology, this next generation of treatment has been fully supported by experts in this field
Mixiii International Competition (Tel Aviv, Israel)
Xi'an International Entrepreneurship Competition (Xi’an, China)
Chengdu International Innovation and Entrepreneurship Competition (London Stop)
THE 3RD CHINA-ISRAEL INNOVATION AND ENTREPRENEURSHIP CONTEST SEMIFINAL FOR LIFE SCIENCE GROUP
At Betalin we’re passionate about our mission to cure diabetes and as the company continues to grow, we will expand our team of researchers and business developers. If you believe you’d make a good addition to our team, we invite you to submit your resume.